Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript
Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc.
Source: insidermonkey.com
📰 Life Sciences Reagents News
Life Sciences Reagents News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Life Sciences Reagents. Real-time updates on events, politics, business and more.
Revvity : Q1 2024 Earnings Transcript - MarketScreener
Revvity, Inc. NYSE:RVTY Earnings Call Monday, April 29, 2024 1:00 PM GMT CALL...
Source: marketscreener.com
KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder
Combination of Biosynth Carbosynth and vivitide creates global life sciences platform serving high-growth biopharma and diagnostics end markets KKR, a leading global investment firm, announced today
United States Noord Holland Kugan Sathiyanandarajah Finsbury Glover Hering Alastair Elwen Sophia Johnston Urs Spitz
Source: finanznachrichten.de